Cannara Biotech Inc. Reports Q1 2023 Financial Results
Company recorded $10.3 million in quarterly revenue; a 57% increase compared to Q1 2022
Delivered its seventh consecutive quarter of positive Adjusted EBITDA of $1.7M and reported positive net incom…